Background: The worldwide demand for ECMO support has grown. Its provision remains limited due to several factors (high cost, complicated technology, lack of expertise) that increase healthcare cost. Our goal was to assess if an intensive care unit (ICU)-run ECMO model without continuous bedside perfusionists would decrease costs while maintaining patient safety and outcomes. Method: A new ECMO program was implemented in 2010, consisting of dedicated ICU multidisciplinary providers (ICU-registered nurses, mid-level providers and intensivists). In year one, we introduced an education platform, new technology and dedicated space. In year two, continuous bedside monitoring by perfusionists was removed and new management algorithms designating multidisciplinary providers as first responders were established. The patient safety and cost benefit from the removal of the continuous bedside monitoring of the perfusionists of this new ECMO program was retrospectively reviewed and compared. Results: During the study period, 74 patients (28 patients in year 1 and 46 patients in year 2) were placed on ECMO (mean days: 8 ± 5.7). The total annual hospital expenditure for the ECMO program was significantly reduced in the new model ($234,000 in year 2 vs. $600,264 in year 1), showing a 61% decrease in cost. This cost decrease was attributed to a decreased utilization of perfusion services and the introduction of longer lasting and more efficient ECMO technology. We did not find any significant changes in registered nurse ratios or any differences in outcomes related to ICU safety events. Conclusion: We demonstrated that the ICU-run ECMO model managed to lower hospital cost by reducing the cost of continuous bedside perfusion support without a change in outcomes.
Introduction
Extracorporeal membrane oxygenation (ECMO) is an advance life-support that incorporates the use of a cardiopulmonary bypass circuit to sustain the cardiovascular and pulmonary system via hemodynamic support and gas exchange. Given the historical complexities of its usage and dismal survival rates, 1 an international consortium, "Extracorporeal Life Support Organization (ELSO)", has been established to support ECMO centers through continuing education and guideline development. The guidelines consisted of the ideal institutional requirements for the effective use of ECMO, including a proper organization structure, staffing issues, physical facilities and equipment, staff training with continuing education, selection criteria, patient follow-up and program evaluation. 2 Despite this, there is still a variation in the implementation of ECMO programs among centers, leading to the popular belief that the varying survival rates reported in the literature are due to a non-standardized approach, especially in volume institutions. 3 The failure of standardization among centers can be attributed to the lack of specialized ECMO-trained staff (ECMO specialists). This shortage was highlighted during the H1N1 pandemic in 2009 when this patient population grew. 4 Since then, the demand for ECMO has steadily increased, leading ELSO to develop new guidelines for ECMO centers in 2010. The new guidelines address the perfusionist shortage by allowing board certified nurses who have at least one year of critical care experience to train as ECMO-trained staff specialists. Although this has been shown to expand ECMO availability, financial concerns have been reported in training all ICU providers as potential ECMO specialists. 5, 6 The failure of the ELSO guidelines is that it has not recognized that dedicated ECMO specialists at the bedside are not the answer, but an educated ECMO team at the bedside with up-to-date technology addresses the shortage.
Despite this, the financial concerns were not weighed against the long-term cost benefit of training nurses as ECMO providers, not specialists. Therefore, this study aims to describe the experiences of implementing a new cost-reducing ECMO program model in an ICU setting of an established adult ECMO center, involving multidisciplinary providers (registered nurses, mid-level providers, respiratory therapists and intensivists) as ECMO providers. This study will also show the cost benefit of the new ECMO model in terms of hospital expenditure, patient safety and outcomes.
Methods
The new ECMO model was introduced in July 2010 in our institution. An adult ECMO program was established with the consensus of the surgical cardiac critical care director, other intensivists, hospital and nursing administration, staff nurses, unit manager, clinical nurse specialist and perfusionists. During the first year, new technology and an educational program were introduced for all levels of staff, including physicians.
New technology was introduced to replace and update the previously used systems of the ECMO circuit. The ROTAFLOW pump (Maquet Cardiovascular LLC, San Jose, CA) was used to replace the Medtronic Biomedicus centrifugal pump (Medtronic, Langhorne, PA). The Quadrox D, a low-pressure oxygenator (Maquet Cardiovascular LLC) was used to replace the Avecor oxygenators (Medtronic). The CardioHelp system (Maquet Cardiovascular LLC) was also introduced as a portable cardiopulmonary support system. Finally, the Servo-I (Maquet Cardiovascular LLC) ventilator was introduced to transport and maintain difficult ventilation in ECMO patients. The circuit was simplified to include the oxygenator and ROTAFLOW pump in a closed-loop design. There were no points of access into the circuit, reservoir or pressure lines pre or post oxygenator. All cannulae were inserted through a percutaneous approach.
The education platform ( Table 1) was developed by a multidisciplinary collaboration, involving intensivists, perfusionists and nursing staff. An outside consultant who specialized in ECMO therapy, in conjunction with the ICU nurse educator and perfusionists, initially provided the education. The education was provided to the ICU team, including staff physicians, residents, registered nurses, mid-level providers, physical therapists and respiratory therapists. It consisted of three main components, which were didactic sessions, hands-on sessions in the wet-labs and competency tests. These requirements were summarized in a competency checklist that the trainee had to complete by the end of the training course. The didactic sessions mainly focused on the existing fundamental knowledge on ECMO and cardiopulmonary physiology. Included in these didactic sessions were discussions related to the institutional adult ECMO policy and procedures, including cardiac and pulmonary indications, various ventilator settings and management while on ECMO, common complications, ECMO contraindications, patient and circuit monitoring, ECMO troubleshooting procedures and emergency management protocols. Simulation training or hands-on sessions were held in a dedicated space in the hospital allocated for the training of all ECMO providers and was termed wet-labs (saline-primed ECMO circuit). During these sessions, the trainees learned to operate the ECMO console and tubing system, including hand cranking for emergency situations. Both the didactic sessions and wet-labs were taught by a chief perfusionist, an outside consultant and the clinical nurse educator. At the completion of the training process, trainees were required to undergo a competency test. This test and training was held annually, even after the completion of the initial training course, to ensure continuous competency among the ICU staff. Each trainee's competency checklist was also assessed for completion. The goal of the education platform was to provide knowledge and experience in monitoring the ECMO circuit and patient, troubleshooting procedures and identifying and preventing complications.
The second major component of the ICU-run ECMO model included the allocation of a dedicated space, the development of treatment algorithms for ECMO providers, the introduction of ECMO-trained personnel and the reduction of bedside responsibility by the perfusionists.
The allocation of a dedicated space for the ECMO patients was decided upon by room availability, accessibility and location size factors. Based on these factors, a dedicated cardiovascular ICU was selected as the best location for the implementation of the model.
The algorithms developed included protocols for anticoagulation, hemodynamic management, oximetry, nutrition, ventilation management, sedation, surgical interventions, ECMO weaning criteria and requirements for the transport (both within the hospital and outside of the hospital) of patients who require ECMO support. These algorithms were developed by the surgical cardiac critical care director and modified accordingly, based on feedback given by ECMO providers, nurses, residents and others. Concerns and suggestions for the algorithms were addressed in multidisciplinary conferences, involving the unit director, intensivists, residents, perfusionists, mid-level providers and nurses. These were held regularly during the initial implementation of the program to ensure quick and effective evaluation and modification of the treatment algorithms. The unit director also conducted daily rounds to ensure proper implementation of the treatment protocols.
In the second year, continuous bedside monitoring by the perfusionists was discontinued. This marked the transition of responsibilities as it related to the ECMO patient. The perfusionists remained responsible for priming the circuit and support during the initial startup of therapy. Initially, the ECMO patients had a 2:1 nurse to patient ratio (same for both years) for the first 12-24 hours. After the patient was stable on ECMO support, the perfusionist was not required to stay at the bedside or in-hospital. The ICU nurse became responsible for the patient and monitoring the effectiveness of ECMO therapy and for any problems with the circuit. After the transition of care, the perfusionists were required to be available to troubleshoot any circuitrelated issue. Since many patients were supported on ECMO for longer than a day (mean duration of support was 8 days), the perfusionists were required to conduct daily rounds on the patients and assist in management strategies, troubleshooting and assessment. The bedside nurse (1:1 nurse to patient ratio) was responsible for ongoing management and identification of patient-or circuit-related problems (single care-giver model). If the patient required an intervention to either clinical care or the circuit, the unit-based mid-level provider was notified. The mid-level provider was able to prescribe changes to the ECMO therapy within their scope of practice; this included speed, sweep or FiO 2 adjustments. If there was a problem with the circuit that required manipulation, adjustment or exchange of a component, the perfusionist and intensivist on call would be notified and respond appropriately. This ECMO model achieved completion in July 2012.
To measure the cost benefit of the new ICU-run ECMO model, adult patients who required ECMO therapy in our institution from July 2010 to July 2012 were retrospectively reviewed after approval by the institutional review board. Pediatric patients (17 years old and below) and those who were transferred from outlying hospital centers already on ECMO support were excluded from this study. The following variables were collected: demographic factors (age, gender, body mass index), primary diagnosis necessitating ECMO, associated medical history, SOFA score and APACHE II score, and duration of treatment. The patients were divided into two groups: the service model of ECMO during the first year (ECMO with the perfusionist with new technology and education -Group 1); the new ECMO model during the second year (ICU managed with new technology and education, Group 2).
The hospital cost of the perfusion service incurred by ECMO patients (cost of ECMO setup and the cost of the perfusionist's monitoring fee between service models) was compared between the first year and second year of the ECMO program. Hospital accounting and billing records were reviewed to obtain the cost to set up an ECMO circuit and perfusionist's monitoring fee. The perfusion services at this institution involve an outside vendor who provides services on a contract basis. The hospital cost to set up an ECMO circuit was $834 and the perfusionist's monitoring fee was $101/ hour during the first year. A monthly retainer fee was introduced in the 2nd year, replacing the setup and the ECMO circuitry, the time spent at the bedside for stabilization for the first 24 hours and daily circuit checks. This retainer fee also included the training and development of nurse competencies. The hardware costs for the initial setup of the ECMO was unchanged in the 1st and 2nd years. The cost to set up the ECMO and the perfusionist's hourly monitoring fee were only applicable for the first year, while the monthly retainer fee was only applicable for the second year. Indirect costs of the ECMO, such as laboratory, x-rays and medications, were not included in this study. The mean annual costs during the 1st and 2nd years were calculated and compared. The number of safety issues (complications derived from incompetency) and outcomes (mortality) were compared between the two groups.
Data are expressed as number, with percentage or mean, with standard deviation as appropriate. Statistical analyses were performed with Stata (Stata Co, College Station, TX). Two-group comparison was performed with Chi-squared or Student's t-tests or the Mann-Whitney U test (2-sided) as appropriate. A p-value less than 0.05 was considered significant.
Results
During the study period, a total of 74 patients were placed in ECMO in our institution and all were included in the study. The basic patient characteristics are shown in Table 2 .
Of the 74 patients, 38% (n=28) were treated during the 1st year of the ECMO model (Group 1) while the remaining 62% (n=46) were treated during the 2nd year (Group 2). There were no significant differences in patient demographics, medical history, primary diagnosis, type of ECMO device and duration of the ECMO therapy between the two groups. The patients in Group 2 were sicker compared to Group 1 (higher APACHE II and SOFA score).
In Group 1, the annual total perfusionist hourly monitoring fee was $576,912, along with the ECMO set of $23,352. In year 1, the total annual ECMO cost incurred from Group 1 was $600,264. In year 2, the total retainer fee for Group 2 was $234,000. This fee includes the ECMO setup fee without any additional hourly monitoring fee; the total annual ECMO cost incurred from Group 2 was only $234,000. Therefore, Group 2 led to an annual cost savings of $366,264 ( Table 3 ).
The mortality rates between the two groups were not significantly different; 42% (n=12) in Group 1 versus 59% (n=27) in Group 2, p=0.233). Circuit exchange due to thrombus in the oxygenator was observed at 11% (n=3) in Group 1 and 11% (n=5) in Group 2 (p=0.650). In terms of adverse safety events, an isolated event of dislodged central cannula was observed in Group 2. Upon review, it was deemed that the event did not occur because of incompetence of ICU staff, but it was related to the loosely inserted cannula into the atrium. No other adverse safety event occurred in either group.
Discussion
There have been mixed opinions regarding the benefits of implementing a non-perfusionist run ECMO model, despite 2010 revised ELSO guidelines. [5] [6] [7] The University of Michigan reported an expansion in the availability of ECMO with no adverse safety events or complications related to nurses in the Primary Care Group (PCG) model. 5 In addition, they were able to allocate more staffing members to manage ECMO in lung transplant patients. On the other hand, concerns on the additional time needed to train new ECMO specialists and the possibility of adverse events deterred an institution from recruiting non-perfusionist staff as ECMO specialists. 7 Nurses in a Scottish ICU who were new ECMO specialists also reported the feeling of inadequacy and the need for regular competency tests to maintain their skills in managing ECMO. 6 Nevertheless, there was a general consensus that implementing a non-perfusionist run ECMO model would require additional financial resources.
In our study, we found safety remains the same between Group 1 while one nurse and one perfusionist are at the ECMO patient's bedside and Group 2 while only one nurse is at the bedside (single care-giver model). We also found that there was significant hospital cost savings with a non-perfusionist, single-care mode, using trained ICU staff to care for and manage patients supported on ECMO. This was mainly due to the omission of the perfusionist's monitoring fee for service charges. Although our institution was required to pay a fixed fee per month (monthly retainer fee) regardless of the number of ECMO cases, our total end cost was still less expensive compared to the total cost of the previous model. This was because of the increase in ECMO circuit availability and, therefore, increases in the number of ECMO patients in the new model. It was calculated that the minimum breakeven point for this financial model to be cost-beneficial was 1 patient for 7.7 days on ECMO per month (our mean ECMO duration was 7.9 days). Although we are a registered ECMO center in the country, our institution has a moderate number of ECMO patients compared to other larger ECMO institutions. This could potentially lead to the lack of confidence and the erosions of skills in handling ECMO patients. 6 To prevent this, we conducted regular competency tests and training courses. These competency tests and training courses have helped the multidisciplinary group of ECMO providers to maintain their skills and gain confidence in handling ECMO patients. In addition, the open relationship between the perfusionists and ICU staff helped all feel secure, as there was someone they could turn to if a complication arose.
From the perfusionists' perspective, the introduction of this new ECMO model has allowed them to allocate more time in the operating room. Initially, they were hesitant to transition continuous care to the ICU model and they were not confident in the ICU team's capability in handling ECMO patients. However, after observing the success of the new team approach, they felt that the model has streamlined and simplified their duties. There was a non-significant increase of mortality in Group 2 compared to Group 1; however, it was most likely due to the higher risk patients in Group 2 (higher SOFA score and APACHE II score) and most likely not related to the change in the management.
There are those who are still concerned about this model for various reasons. First, that anyone other than a perfusionist "managing an ECMO circuit" may be outside the scope of practice. Second, that a patient is unsafe with "nurses managing the ECMO circuit". The keys to achieving the clinical outcomes presented above should not be overlooked. Nurses were not asked to manage the circuit, but, rather, were asked to manage the patient and monitor the circuit, similar to that of a ventricular assist device. Similarly, the perfusionists were still solely responsible for the management of the system. 8 They exchanged the circuit or oxygenator if required, they went on transports outside the unit and they were present for both initiation and weaning off support. After this study, a protocol was made in our institution regarding the responsibility of the perfusionist and the ICU team, which is the same as the 2nd year of the study. Without the change to updated technology, the ICU model for the management of patients on ECMO should not be considered.
There were several limitations to this study. Firstly, the number of patients involved in this study was limited. A larger sample size could potentially increase the amount of cost savings, as the monthly retainer fee is constant. Secondly, the diversity of disease processes managed did not allow for comparisons between respiratory vs. cardiac failure. Finally, we employed a third party to train ICU staff and perfusionists on a limited time contract. This could potentially lead to additional financial biases. We ensured that this was not the case as they were not involved in any decision-making in this model and were never present in any of the meetings and discussions that took place during the implementation of the new ECMO model.
Conclusion
The new ICU-run ECMO program implemented in our study is cost beneficial without adverse safety events or complications related to the new ICU-managed ECMO model. The introduction of this model has managed to expand the availability of ECMO, which influenced cost savings. The new ICU-run ECMO program is truly exciting because the known high cost of managing an ECMO patient could be reduced without implications to outcomes.
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